Halozyme Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $692M | 18M | 38.20 |
| 2023-06-30 | $671M | 19M | 36.07 |
| 2023-03-31 | $693M | 18M | 38.19 |
| 2022-12-31 | $1.0B | 18M | 56.90 |
| 2022-06-30 | $809M | 18M | 44.00 |
| 2021-06-30 | $866M | 19M | 45.41 |
| 2021-03-31 | $769M | 18M | 41.69 |
| 2020-12-31 | $789M | 19M | 42.71 |
| 2020-09-30 | $347M | 13M | 26.28 |
| 2020-03-31 | $219M | 12M | 17.99 |
| 2019-12-31 | $215M | 12M | 17.73 |
| 2019-09-30 | $202M | 13M | 15.51 |
| 2019-06-30 | $217M | 13M | 17.18 |
| 2019-03-31 | $188M | 12M | 16.10 |
| 2018-12-31 | $172M | 12M | 14.63 |
| 2018-09-30 | $216M | 12M | 18.17 |
| 2018-06-30 | $207M | 12M | 16.87 |
| 2018-03-31 | $227M | 12M | 19.59 |
| 2017-09-30 | $211M | 12M | 17.37 |
| 2016-12-31 | $1.5M | 150k | 9.88 |
| 2016-09-30 | $264k | 22k | 12.09 |
| 2016-06-30 | $182k | 21k | 8.62 |
| 2016-03-31 | $67k | 7.1k | 9.52 |
| 2015-12-31 | $53k | 3.1k | 17.16 |
| 2015-09-30 | $52k | 3.8k | 13.64 |
| 2015-06-30 | $70k | 3.1k | 22.73 |
| 2015-03-31 | $48k | 3.2k | 14.77 |
| 2014-12-31 | $29k | 3.2k | 9.09 |
| 2014-09-30 | $29k | 3.2k | 9.09 |
| 2014-06-30 | $33k | 3.2k | 10.23 |
| 2014-03-31 | $41k | 3.3k | 12.50 |
| 2013-12-31 | $46k | 3.1k | 14.77 |
| 2013-09-30 | $37k | 3.3k | 11.36 |
| 2013-06-30 | $26k | 3.3k | 7.95 |